NEW YORK ,
July 17, 2020 /PRNewswire/ -- Halper
Sadeh LLP, a global investor rights law firm, is investigating
whether the following mergers are fair to shareholders. Halper
Sadeh LLP may seek increased consideration, additional disclosures
and information concerning the proposed transaction, or other
relief and benefits on behalf of shareholders:
International Flavors & Fragrances Inc. (NYSE:
IFF)
The investigation concerns whether IFF and its board of
directors violated the federal securities laws and/or breached
their fiduciary duties to shareholders in connection with the
proposed merger between IFF and DuPont's Nutrition &
Biosciences business. Under the terms of the merger, DuPont
shareholders will own approximately 55.4% of the combined company
and IFF shareholders will own approximately 44.6%. If you are an
IFF shareholder and would like to learn more about your legal
rights and options, please visit:
https://halpersadeh.com/actions/international-flavors-fragrances-inc-iff-stock-merger-dupont/.
Garrison Capital Inc. (NASDAQ: GARS)
The investigation
concerns whether Garrison Capital and its board of directors
violated the federal securities laws and/or breached their
fiduciary duties to shareholders in connection with the proposed
sale of Garrison Capital to Portman Ridge Finance
Corporation. Following the proposed transaction, Garrison
Capital shareholders are expected to own approximately 41.6% of the
combined company. If you are a Garrison Capital shareholder and
would like to learn more about your legal rights and options,
please visit:
https://halpersadeh.com/actions/garrison-capital-inc-gars-portman-ridge-stock-merger/.
Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN)
The
investigation concerns whether Rexahn Pharmaceuticals and its board
of directors violated the federal securities laws and/or breached
their fiduciary duties to shareholders in connection the merger
between Rexahn Pharmaceuticals and Ocuphire Pharma, Inc. If you are
a Rexahn Pharmaceuticals shareholder and would like to learn more
about your legal rights and options, please visit:
https://halpersadeh.com/actions/rexahn-pharmaceuticals-inc-rexn-stock-merger-ocuphire/.
Analog Devices, Inc.
The investigation concerns
whether Analog Devices, Inc. and its board of directors violated
the federal securities laws and/or breached their fiduciary duties
to shareholders in connection with the merger between Analog
Devices and Maxim Integrated Products, Inc. Under the terms of the
agreement, Maxim stockholders will receive 0.630 shares of Analog
Devices common stock for each share of Maxim common stock they hold
at closing. Upon closing, current Analog Devices stockholders will
own approximately 69% of the combined company while Maxim
stockholders will own approximately 31%. If you are an Analog
Devices shareholder and would like to learn more about your legal
rights and options, please visit:
https://halpersadeh.com/actions/analog-devices-inc-adi-stock-merger-maxim-integrated-products-mxim.
Shareholders are encouraged to contact the firm free of
charge to discuss their legal rights and options. Please call
Daniel Sadeh or Zachary Halper at (212) 763-0060 or email
sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLP represents investors all over the world
who have fallen victim to securities fraud and corporate
misconduct. Our attorneys have been instrumental in implementing
corporate reforms and recovering millions of dollars on behalf of
defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/investigation-alert-halper-sadeh-llp-is-investigating-whether-the-following-mergers-are-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm-301095630.html
SOURCE Halper Sadeh LLP